July 17, 2019
Prof. Makoto Yamashita Cases of infection by resistant viruses to the anti-influenza drug Xofluza (baloxavir marboxil) were found in the 2018-2019 flu season, and the next thing that should be of concern is the expansion and spread of resistant viruses,”...read more